secwatch.observer — SEC 8-K summary
======================================

Issuer:     Liminatus Pharma, Inc. (LIMN)
CIK:        0001971387
Form:       8-K
Filed at:   2025-07-17T23:59:59+00:00
Accession:  0001104659-25-068670
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Liminatus Pharma exchanges 1M warrants for 350K shares with Alta Partners
-------------------------------------------------------------------------

- Company issued 350,000 shares of common stock to Alta Partners in exchange for surrender and cancellation of 1,000,000 warrants.
- No commission or other remuneration was paid in connection with the exchange.
- Shares were issued in reliance on the Section 3(a)(9) exemption from registration.
- The transaction reduces potential dilution from outstanding warrants by 650,000 shares on a net basis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1971387/000110465925068670/0001104659-25-068670-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1971387/000110465925068670/tm2521089d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-068670

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer